Qube Research & Technologies (QRT) Portfolio holdings
AUM
$72B
1-Year Return
7.86%
This Quarter Return
+14.57%
1 Year Return
+7.86%
3 Year Return
+23.62%
5 Year Return
+38.38%
10 Year Return
–
AUM
$6.69B
AUM Growth
-$135M
(-2%)
Cap. Flow
-$669M
Cap. Flow
% of AUM
-9.99%
Top 10 Holdings %
Top 10 Hldgs %
17.38%
Holding
2,386
New
774
Increased
417
Reduced
542
Closed
634
Top Buys
Top Sells
| 1 |
iShares US Treasury Bond ETF
GOVT
|
+$126M |
| 2 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$57.9M |
| 3 |
Visa
V
|
+$48.3M |
| 4 |
JPMorgan Chase
JPM
|
+$46.1M |
| 5 |
iShares 3-7 Year Treasury Bond ETF
IEI
|
+$44.7M |
Sector Composition
| 1 | Technology | 13.38% |
| 2 | Healthcare | 8.61% |
| 3 | Financials | 7.58% |
| 4 | Industrials | 7.34% |
| 5 | Consumer Discretionary | 6.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1401
Vicor
VICR
$2.27B
| $264K | ﹤0.01% |
+2,865
| New | +$264K |
|
1402
Sturm, Ruger & Co
RGR
$605M
| $263K | ﹤0.01% |
4,039
-326
| -7% | -$21.2K |
|
1403
Spire
SR
$4.48B
| $263K | ﹤0.01% |
+4,113
| New | +$263K |
|
1404
SPDR NYSE Technology ETF
XNTK
$1.32B
| $263K | ﹤0.01% |
1,861
+318
| +21% | +$44.9K |
|
1405
Iovance Biotherapeutics
IOVA
$858M
| $262K | ﹤0.01% |
5,652
-5,934
| -51% | -$275K |
|
1406
Permian Resources
PR
$9.8B
| $262K | ﹤0.01% |
+174,825
| New | +$262K |
|
1407
WSFS Financial
WSFS
$3.14B
| $262K | ﹤0.01% |
+5,843
| New | +$262K |
|
1408
Seacoast Banking Corp of Florida
SBCF
$2.69B
| $260K | ﹤0.01% |
+8,832
| New | +$260K |
|
1409
AMC Entertainment Holdings
AMC
$1.43B
| $258K | ﹤0.01% |
+12,160
| New | +$258K |
|
1410
Medpace
MEDP
$13.8B
| $258K | ﹤0.01% |
1,855
-12,153
| -87% | -$1.69M |
|
1411
Brookfield Renewable
BEP
$7.13B
| $257K | ﹤0.01% |
5,950
-5,263
| -47% | -$227K |
|
|
EGRX
1412
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $257K | ﹤0.01% |
+5,520
| New | +$257K |
|
|
ACGN
1413
DELISTED
Aceragen, Inc. Common Stock
ACGN
| $257K | ﹤0.01% |
4,129
-6,279
| -60% | -$391K |
|
1414
Ziff Davis
ZD
$1.52B
| $256K | ﹤0.01% |
3,014
-30,418
| -91% | -$2.58M |
|
|
DBD
1415
DELISTED
Diebold Nixdorf Incorporated
DBD
| $256K | ﹤0.01% |
23,991
-39,356
| -62% | -$420K |
|
1416
AMN Healthcare
AMN
$713M
| $255K | ﹤0.01% |
+3,739
| New | +$255K |
|
1417
Goosehead Insurance
GSHD
$2.05B
| $255K | ﹤0.01% |
2,046
-1,084
| -35% | -$135K |
|
1418
iShares Core High Dividend ETF
HDV
$11.7B
| $255K | ﹤0.01% |
+2,911
| New | +$255K |
|
1419
Advent Technologies
ADN
$8.09M
| $254K | ﹤0.01% |
+568
| New | +$254K |
|
1420
CBAK Energy Technology
CBAT
$78.8M
| $254K | ﹤0.01% |
+50,150
| New | +$254K |
|
1421
Leap Therapeutics
LPTX
$12.1M
| $254K | ﹤0.01% |
11,285
-12,877
| -53% | -$290K |
|
1422
Plexus
PLXS
$3.75B
| $254K | ﹤0.01% |
3,248
-5,578
| -63% | -$436K |
|
1423
Vericel Corp
VCEL
$1.64B
| $254K | ﹤0.01% |
8,240
-20,678
| -72% | -$637K |
|
1424
Option Care Health
OPCH
$4.75B
| $253K | ﹤0.01% |
+16,149
| New | +$253K |
|
1425
BioAtla
BCAB
$47.7M
| $252K | ﹤0.01% |
+7,400
| New | +$252K |
|